Qiagen Appoints Jonathan Pratt as CEO Amid Ongoing Takeover Discussions

Qiagen has announced the appointment of Jonathan Pratt as its new Chief Executive Officer. This leadership change comes as the company continues to engage in discussions regarding a potential sale.

24 Aug, 13:41 — 24 Aug, 13:41

Post Share

Sources

Showing 1 of 2 sources

bloombergHigh1d ago

Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress

Qiagen NV has appointed Jonathan Pratt as its new chief executive officer, as talks with private equity firms about a possible sale of the European molecular testing company progress.

By Eyk Henning, Dinesh Nair, Swetha Gopinath and Crystal Tse

Read full article →

Coverage Timeline

First report: bloomberg · 24 Aug, 13:41|Full coverage: 2 · 15m|Window: 15m

Left-leaningCenterRight-leaning

bloomberg24 Aug, 13:41First to report

Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress

investing-com24 Aug, 13:56Latest update

PERSPECTA

PERSPECTA

Qiagen Appoints Jonathan Pratt as CEO Amid Ongoing Takeover Discussions

Sources

Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress

Coverage Timeline

Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress

Qiagen names Jonathan Pratt as CEO amid takeover talks

Related Stories

Canada Imposes Retaliatory Tariffs on US Goods Amid Trade Dispute

SelectQuote Shares Decline on Q4 Revenue Miss and Weak Outlook

Gatik Raises $200 Million Amid Growing Autonomous Freight Demand

Leonardo Maria Del Vecchio Resigns from EssilorLuxottica Amid Family Dispute

PERSPECTA